Economic Impact of Recurrent Clostridioides  difficile Infection in the USA: A Systematic Literature Review and Cost Synthesis

ConclusionsWhile real-world studies on economic impact of rCDI in the USA suggested a high-cost burden, inconsistency in methodologies and results reporting warranted a component-based cost synthesis approach to estimate the annual medical cost burden of rCDI. Utilizing available literature, we estimated the average annual rCDI-attributable medical costs to allow for consistent economic assessments of rCDI and identify the budget impact on US payers.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research